Table 1 Clinical features of febrile patients with hematological malignancies
Demographic/characteristic | No. patients (%) (n = 72) |
|---|---|
Age (years) | Â |
  Median | 42.5 |
  Range | 3–76 |
Gender | Â |
  Male | 42 (58.3) |
  Female | 30 (41.7) |
Hematological malignancy | Â |
  AML | 30 (41.7) |
  ALL | 10 (13.9) |
  CML | 3 (4.2) |
  CMML | 1 (1.4) |
  CLL | 2 (2.8) |
  NHL | 14 (19.4) |
  MDS | 7 (9.7) |
  MM | 5 (6.9) |
HSCT | 25 (34.7) |
  Allo-HSCT | 21 (29.2) |
  Auto-HSCT | 4 (5.6) |
IA | 41 (56.9) |
  Proven | 4 (5.6) |
  Probable | 18 (25) |
  Possible | 19 (26.4) |
Sites | Â |
  Pulmonary | 40 (55.6) |
  Systemic | 1 (1.4) |